Even if RFK Jr. fires everyone at the FDA, if won’t matter because he doesn’t know anyone with the ‘technical expertise’ to alter the rules, former chief counsel says
Donald Trump has tapped vaccine-skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
FDA employees consider leaving if RFK Jr. is appointed as HHS secretary
NBC News' Berkeley Lovelace Jr. reports that some officials in the Food and Drug Administration are grappling with how to ...
McDonald's Onion Recall Update as FDA Sets Highest Risk Level
The FDA has issued a Class I risk classification for a large number of recalled onions produced by Taylor Farms.
Cure Today18m
FDA Approves Revuforj for Relapsed/Refractory Acute Leukemia Subset
Revuforj was approved by the FDA for adults and children with relapsed/refractory acute leukemia with a KMT2A translocation.
Is the FDA contributing to the homelessness crisis?
The FDA’s REMS program has been found to have unintentionally created barriers to accessing clozapine, a crucial ...
STAT12h
FDA commissioner: We need action and higher-quality research on ultra-processed foods
Researchers, public health and health care groups, advocates, industry, and the public must put tackling diet-related disease ...
Becker's Hospital Review1h
FDA warns of arterial bypass device safety concerns: 5 things to know
The FDA has warned providers of safety concerns and supply issues for Getinge/Maquet's VasoView HemoPro Endoscopic Vessel Harvesting Systems. The device is primarily used during endoscopic arterial ...
oncnursingnews48m
FDA Approves Revumenib for Relapsed, Refractory Acute Leukemia With a KMT2A Translocation
The FDA has approved revumenib (Revuforj) for the treatment of adult and pediatric patients aged 1 year and older with ...
New FDA rules for TV drug ads: Simpler language and no distractions
The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...
Targeted Oncology6h
FDA Approves Nilotinib With No Mealtime Restrictions in Ph-Positive CML
The FDA has approved a re-engineered formulation of nilotinib with no mealtime restrictions for adult patients with newly ...